ES2141095T3 - Anticuerpos monoclonales contra antigenos asociados a tumores, procedimiento para su preparacion y su uso. - Google Patents

Anticuerpos monoclonales contra antigenos asociados a tumores, procedimiento para su preparacion y su uso.

Info

Publication number
ES2141095T3
ES2141095T3 ES92115878T ES92115878T ES2141095T3 ES 2141095 T3 ES2141095 T3 ES 2141095T3 ES 92115878 T ES92115878 T ES 92115878T ES 92115878 T ES92115878 T ES 92115878T ES 2141095 T3 ES2141095 T3 ES 2141095T3
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
tumors
procedure
preparation
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92115878T
Other languages
English (en)
Inventor
Klaus Bosslet
Gerhard Seemann
Peter Pfleiderer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6442537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2141095(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2141095T3 publication Critical patent/ES2141095T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3038—Kidney, bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PRESENTE INVENCION CONCIERNE A ANTICUERPOS MONOCLONALES, CONTRA UN ANTIGENO ASOCIADO A UN TUMOR, A UN TUMOR DE ORIGEN PREFERENTEMENTE DEL GRUPO DE CARCINOMAS DE MAMA, OVARIO, PROSTATA ASI COMO ADENOCARCINOMAS DE PULMON, QUE REACCIONAN ADICIONALMENTE CON LA "MUCINA POLIMORFICA EPITELIAL" (PEM), SU OBTENCION Y UTILIZACION, ASI COMO LA UTILIZACION DE LOS EPITOPES DEFINIDOS POR LOS ANTICUERPOS, PARA EL DIAGNOSTICO Y TERAPIA.
ES92115878T 1991-10-11 1992-09-17 Anticuerpos monoclonales contra antigenos asociados a tumores, procedimiento para su preparacion y su uso. Expired - Lifetime ES2141095T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4133791A DE4133791A1 (de) 1991-10-11 1991-10-11 Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
ES2141095T3 true ES2141095T3 (es) 2000-03-16

Family

ID=6442537

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92115878T Expired - Lifetime ES2141095T3 (es) 1991-10-11 1992-09-17 Anticuerpos monoclonales contra antigenos asociados a tumores, procedimiento para su preparacion y su uso.

Country Status (11)

Country Link
US (4) US5639621A (es)
EP (1) EP0537489B1 (es)
JP (1) JP3996649B2 (es)
AT (1) ATE187463T1 (es)
AU (1) AU670247B2 (es)
CA (1) CA2080260C (es)
DE (2) DE4133791A1 (es)
ES (1) ES2141095T3 (es)
FI (1) FI924543A7 (es)
NZ (1) NZ244661A (es)
ZA (1) ZA927785B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0636029B1 (en) * 1992-04-13 2000-11-08 Dana-Farber Cancer Institute, Inc. Antibodies specific for carcinoma-associated antigens
US6030797A (en) * 1992-10-08 2000-02-29 Dade Behring Marburg Gmbh Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof
US6207805B1 (en) 1997-07-18 2001-03-27 University Of Iowa Research Foundation Prostate cell surface antigen-specific antibodies
JP3992298B2 (ja) * 1997-10-03 2007-10-17 中外製薬株式会社 天然ヒト型化抗体
US6881405B2 (en) 1998-06-15 2005-04-19 Altarex Medical Corp. Reagents and methods for inducing an immune response to prostate specific antigen
ATE553131T1 (de) * 2000-05-08 2012-04-15 Celldex Res Corp Humane monoklonale antikörper gegen dendritische zellen
RU2198681C2 (ru) * 2000-12-27 2003-02-20 Московский научно-исследовательский онкологический институт им. П.А. Герцена Моноклональное антитело ико25, специфичное к антигену мис1, противоопухолевое средство
US6949629B2 (en) * 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins
WO2007081779A2 (en) * 2006-01-05 2007-07-19 Genentech, Inc. Methods of determining cutoff points
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640033A (en) * 1979-09-07 1981-04-16 Fujitsu Ltd Cold water type cooling system utilizing open air for cooling water
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0256654B1 (en) * 1986-07-07 1996-09-18 Centocor, Inc. Chimeric murine/human immunoglobulin specific for tumour-associated 17-1A Antigen
DE3825615A1 (de) * 1988-07-28 1990-02-01 Behringwerke Ag Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung
US5185254A (en) * 1988-12-29 1993-02-09 The Wistar Institute Gene family of tumor-associated antigens
DE3909799A1 (de) * 1989-03-24 1990-09-27 Behringwerke Ag Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
EP0397419A3 (en) * 1989-05-10 1991-04-03 Hybritech Incorporated Novel tumor-associated antigen, antibodies, compositions and uses therefor
WO1991002079A1 (en) * 1989-07-31 1991-02-21 The University Of British Columbia Monoclonal antibodies against a tumor-associated antigen
DE4005630A1 (de) * 1990-02-22 1991-09-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
US5837824A (en) 1998-11-17
AU670247B2 (en) 1996-07-11
US5695758A (en) 1997-12-09
FI924543L (fi) 1993-04-12
AU2629892A (en) 1993-04-22
EP0537489A1 (de) 1993-04-21
JPH05317088A (ja) 1993-12-03
US5674994A (en) 1997-10-07
FI924543A7 (fi) 1993-04-12
JP3996649B2 (ja) 2007-10-24
US5639621A (en) 1997-06-17
FI924543A0 (fi) 1992-10-08
DE4133791A1 (de) 1993-04-15
ATE187463T1 (de) 1999-12-15
CA2080260A1 (en) 1993-04-12
ZA927785B (en) 1994-04-11
NZ244661A (en) 1995-10-26
DE59209776D1 (de) 2000-01-13
CA2080260C (en) 2002-12-17
EP0537489B1 (de) 1999-12-08

Similar Documents

Publication Publication Date Title
ES2053440T3 (es) Anticuerpos monoclonales anti-cancer de mama humano, correspondientes hibridomas, la produccion y utilizacion de los mismos.
ES2059413T3 (es) Anticuerpos monoclonales contra antigenos asociados a melanoma, progenies celulares hibridas que producen estos anticuerpos, y su empleo correspondiente.
EP0265500A4 (en) ANTIBODIES AGAINST HUMAN PROGESTERONE RECEPTOR AND DIAGNOSTIC PRODUCTS AND METHOD.
ZA945364B (en) Antibodies specific for human prostate glandular kallikrein
ES2141095T3 (es) Anticuerpos monoclonales contra antigenos asociados a tumores, procedimiento para su preparacion y su uso.
ES2167391T3 (es) Inmunoconjugados ii.
ES516797A0 (es) Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.
GR3029830T3 (en) Method of preparing a radioactive rhenium complex solution.
ES2113376T3 (es) Conjugados de anticuerpos para tratamiento de enfermedades neoplasticas.
ES8705975A1 (es) Un metodo de deteccion o localizacion de celulas de carcinoma humano.
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
ES463124A1 (es) Procedimiento de obtencion de un complejo antigeno-proteina multivalente para bloquear reacciones alergicas.
NO965395D0 (no) Humane, monoklonale antistoffer som er spesifikke mot cellecyklus-uavhengig gliom-overflateantigen
ES2177509T3 (es) Empleo de anticuerpos para la vacunacion contra el cancer.
ES2061705T3 (es) Procedimiento de obtencion de un preparado antigenico de toxoplasma gondii y sus aplicaciones diagnosticas y profilacticas.
ES2101695T3 (es) Haptoglobina relacionada con el cancer (hpr).
GR3020387T3 (en) Ctaa 28a32, the antigen recognized by mca 28a32
ES318272A1 (es) El procedimiento de preparacion de eter 4-bromo-3-clorodifenilico.
DK102589D0 (da) Antigen, der genkendes af mca 16-88
ES2093135T3 (es) Anticuerpos monoclonales contra el complejo plasmina-antiplasmina, procedimiento para su preparacion asi como su utilizacion.
BG49665A1 (en) Hybridom cell line, secreting monoclonal antibody against determinant 05 salmonelli of group b

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 537489

Country of ref document: ES